© Pint of Science, 2026. All rights reserved.
Join us for an engaging and thought-provoking event that brings together two dynamic areas of research—vision health and energy innovation—highlighting both scientific discovery and the vital role of public engagement.
Our speakers come from a variety of backgrounds and trainings, and aim to cover current scientific, personal, and economic issues. From involving patients in their treatment development and plans, to addressing pressing ocular issues and their solutions, to the world of tech and energy where discussions about emerging battery materials and economic impacts can take place!
Our speakers come from a variety of backgrounds and trainings, and aim to cover current scientific, personal, and economic issues. From involving patients in their treatment development and plans, to addressing pressing ocular issues and their solutions, to the world of tech and energy where discussions about emerging battery materials and economic impacts can take place!
Beyond the Lithium-Ion Empire
Rebekah Attard-Trevisan
(Rebekah Attard-Trevisan has a PhD in materials chemistry focusing on battery technology, and is now working as a STEM Engagement Officer with CALMAST, SETU's STEM Engagement Centre.)
Batteries come in many different shapes and sizes; however, their working principle is the same. The key factor that determines the purpose of a battery is its chemistry and the materials within. There is much research revolving around batteries nowadays in order to replace lithium, but what is the most competitive contender to take its place? Join me in this discussion about the race to replace lithium!
Putting People at the Centre: Public and Patient Involvement in Vision Research
Tess Ames
(Tess Ames is the Ocular Therapeutics Research Group Manager and INNOVISION Programme Manager at the Pharmaceutical and Molecular Biotechnology Research Centre in SETU.)
I will talk about how the Ocular Therapeutics Research Group brings Public and Patient Involvement (PPI) into our work, putting people at the centre of research. Using vision health, discover how you can share your voice, shape research, and get involved in meaningful ways.
Instead of for people with dry eye disease, why not with them? A new way to have better treatments.
Dorsa Golestaneh
(PhD Candidate and a member of the Ocular Therapeutics Research Group in the Pharmaceutical and Molecular Biotechnology Research Centre, )
Dry eye disease (DED) affects millions worldwide, yet current treatments are often sub-optimal. Therefore, we are developing more effective treatments for DED based on the experiences and perceptions of individuals living with it.
Map data © OpenStreetMap contributors.